mycophenolate mofetil [clinicaltrials_resource:3be70f7d41b4f62948fcb35f348937fb]
Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers [clinicaltrials:NCT00003572]Bone Marrow Transplantation in Treating Children With Sickle Cell Disease [clinicaltrials:NCT00004485]Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer [clinicaltrials:NCT00005941]Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00006042]Combination Chemotherapy, Total-Body Irradiation, Peripheral Stem Cell Transplantation, and Lymphocyte Infusion in Treating Patients With Stage IV Melanoma [clinicaltrials:NCT00006233]Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00006350]Study of the Pharmacokinetics of Mycophenolate Mofetil in Patients Who Have Undergone Orthotopic Liver Transplantation [clinicaltrials:NCT00007059]Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00008151]Combination Chemotherapy Followed by Donor Bone Marrow Transplant or Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer or Genetic Disorders [clinicaltrials:NCT00008307]Study of Total Body Irradiation and Fludarabine Followed By Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation in Combination With Cyclosporine and Mycophenolate Mofetil in Patients With Inherited Disorders [clinicaltrials:NCT00010361]Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer [clinicaltrials:NCT00025519]Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia [clinicaltrials:NCT00027547]Comparison of Fludarabine Plus Total-Body Irradiation With Combination Chemotherapy Followed by Donor Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [clinicaltrials:NCT00041288]Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00044954]Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation [clinicaltrials:NCT00096096]Fludarabine and Radiation Therapy in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Phase or Accelerated Phase Chronic Myelogenous Leukemia [clinicaltrials:NCT00110058]clinicaltrials:NCT00119340clinicaltrials:NCT00134004Combination Chemotherapy, Tacrolimus, and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant For Hematologic Cancer [clinicaltrials:NCT00134017]Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection [clinicaltrials:NCT00150891]Study to Evaluate the Amount of Medications That May be Removed From the Body During Plasmapheresis [clinicaltrials:NCT00203281]clinicaltrials:NCT00243009Fludarabine, Cyclophosphamide, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing a Donor Umbilical Cord Blood Transplant for Hematologic Cancer [clinicaltrials:NCT00255684]Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer [clinicaltrials:NCT00255710]Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients [clinicaltrials:NCT00261820]Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer [clinicaltrials:NCT00262886]Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia [clinicaltrials:NCT00281983]Mycophenolate Mofetil in Myasthenia Gravis [clinicaltrials:NCT00285350]Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00290628]Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00290641]Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia [clinicaltrials:NCT00295997]Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases [clinicaltrials:NCT00317785]Combination Chemotherapy Followed By Donor Stem Cell Transplant in Treating Patients With Hemophagocytic Lymphohistiocytosis [clinicaltrials:NCT00334672]Pilot Study for HLA Identical Living Donor Renal Transplant Recipients [clinicaltrials:NCT00352092]Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer [clinicaltrials:NCT00365287]Study to Evaluate Safety and Efficacy of Early Calcineurin Inhibitor Withdrawal in Primary Renal Allografts [clinicaltrials:NCT00374647]Busulfan, Cyclophosphamide, and Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00611351]Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders [clinicaltrials:NCT00740467]Mycophenolate Mofetil Maintenance Therapy for Liver Transplantation [clinicaltrials:NCT00849238]Donor Umbilical Cord Blood Transplant After Cyclophosphamide, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematologic Disease [clinicaltrials:NCT00959231]
intervention [clinicaltrials_vocabulary:intervention]
mycophenolate mofetil [clinicaltrials_resource:3be70f7d41b4f62948fcb35f348937fb]
Bio2RDF identifier
3be70f7d41b4f62948fcb35f348937fb
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3be70f7d41b4f62948fcb35f348937fb
intervention name [clinicaltrials_vocabulary:intervention-name]
mycophenolate mofetil
identifier
clinicaltrials_resource:3be70f7d41b4f62948fcb35f348937fb
title
mycophenolate mofetil
@en
type
label
mycophenolate mofetil [clinicaltrials_resource:3be70f7d41b4f62948fcb35f348937fb]
@en